IDEXX LABORATORIES INC /DE (IDXX) Executive Compensation
IDEXX LABORATORIES INC /DE (IDXX) is a publicly traded company on the Nasdaq, categorized under SIC 2835 (In Vitro & In Vivo Diagnostic Substances). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: IDXX
CIK: 874716
Exchange: Nasdaq
SIC 2835: In Vitro & In Vivo Diagnostic Substances
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerJoshua Herron
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-09 | 2026-09-04 | FORM 4 | 0000874716-26-000127 | View SEC Doc Filr Page |
| 144 | 2026-09-04 | — | 144 Filing | 0001950047-26-009112 | View SEC Doc Filr Page |
| 4 | 2026-08-24 | 2026-08-20 | FORM 4 | 0000874716-26-000125 | View SEC Doc Filr Page |
| 10-Q | 2026-08-04 | 2026-06-30 | 10-Q | 0000874716-26-000123 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-04 | FORM 8-K | 0001104659-26-090033 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-07-30 | FORM 4 | 0000874716-26-000117 | View SEC Doc Filr Page |
| 4 | 2026-06-02 | 2026-06-01 | FORM 4 | 0000874716-26-000114 | View SEC Doc Filr Page |
| SD | 2026-06-01 | — | SD | 0000874716-26-000112 | View SEC Doc Filr Page |
| 144 | 2026-05-20 | — | 144 Filing | 0001958244-26-000299 | View SEC Doc Filr Page |
| 8-K | 2026-05-15 | 2026-05-12 | 8-K | 0000874716-26-000110 | View SEC Doc Filr Page |
| 4 | 2026-05-14 | 2026-05-12 | FORM 4 | 0000874716-26-000107 | View SEC Doc Filr Page |
| 4 | 2026-05-14 | 2026-05-12 | FORM 4 | 0000874716-26-000106 | View SEC Doc Filr Page |
| 4 | 2026-05-14 | 2026-05-12 | FORM 4 | 0000874716-26-000105 | View SEC Doc Filr Page |
| 4 | 2026-05-14 | 2026-05-12 | FORM 4 | 0000874716-26-000104 | View SEC Doc Filr Page |
| 4 | 2026-05-14 | 2026-05-12 | FORM 4 | 0000874716-26-000103 | View SEC Doc Filr Page |
| 4 | 2026-05-14 | 2026-05-12 | FORM 4 | 0000874716-26-000102 | View SEC Doc Filr Page |
| 4 | 2026-05-14 | 2026-05-12 | FORM 4 | 0000874716-26-000101 | View SEC Doc Filr Page |
| 4 | 2026-05-14 | 2026-05-12 | FORM 4 | 0000874716-26-000100 | View SEC Doc Filr Page |
| 4 | 2026-05-14 | 2026-05-12 | FORM 4 | 0000874716-26-000099 | View SEC Doc Filr Page |
| 4 | 2026-05-11 | 2026-05-07 | FORM 4 | 0000874716-26-000088 | View SEC Doc Filr Page |
| 4 | 2026-05-11 | 2026-05-07 | FORM 4 | 0000874716-26-000087 | View SEC Doc Filr Page |
| 4 | 2026-05-11 | 2026-05-07 | FORM 4 | 0000874716-26-000086 | View SEC Doc Filr Page |
| 4 | 2026-05-11 | 2026-05-07 | FORM 4 | 0000874716-26-000085 | View SEC Doc Filr Page |
| 4 | 2026-05-11 | 2026-05-07 | FORM 4 | 0000874716-26-000084 | View SEC Doc Filr Page |
| 4 | 2026-05-11 | 2026-05-07 | FORM 4 | 0000874716-26-000083 | View SEC Doc Filr Page |